Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic CholangiocarcinomaAntonio Cigliano, Kirsten Utpatel|Medicina|2019Cited by 13
Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific VulnerabilitiesAlexander Scheiter, Kirsten Utpatel|Journal of Personalized Medicine|2022Cited by 7
RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Kirsten Utpatel|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1